Transplant Risk in Myelofibrosis Juan Carlos Hernández-Boluda, MD, PhD, an associated physician at the Hematology and Medical Oncology Service of the Hospital Clínico of Valencia, discusses an EBMT machine learning–based model for identifying and stratifying transplant risk for patients with myelofibrosis.

Dr Hernández-Boluda on an EBMT Machine Learning Model for Identifying and Stratifying Transplant Risk in Myelofibrosis

Juan Carlos Hernández-Boluda, MD, PhD, an associated physician at the Hematology and Medical Oncology Service of the Hospital Clínico of Valencia, discusses an EBMT machine learning–based model for identifying and stratifying transplant risk for patients with myelofibrosis.

Videos

Juan Carlos Hernández-Boluda, MD, PhD, discusses an EBMT machine learning–based model for identifying and stratifying transplant risk in myelofibrosis.

Juan Carlos Hernández-Boluda, MD, PhD

Articles

Dr Hernández-Boluda on an EBMT Machine Learning Model for Identifying and Stratifying Transplant Risk in Myelofibrosis